This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignees: Gna Biosolutions Gmbh, Hp Health Solutions Germany Gmbh. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Munich, DE (2016 - 2018)
- Planegg, DE (2018)
- Planegg/Martinsried, DE (2020 - 2023)
Company Filing History:
Years Active: 2016-2026
Title: Unlocking Innovations in Nucleic Acid Amplification: The Contributions of Federico Buersgens
Introduction
Federico Buersgens, an accomplished inventor based in Planegg/Martinsried, Germany, has significantly contributed to the field of nucleic acid amplification. With a portfolio of seven patents, his innovative methods and devices have the potential to revolutionize molecular biology and diagnostics.
Latest Patents
Among his latest patents, Buersgens has developed a groundbreaking method for carrying out a polymerase chain reaction (PCR), which is instrumental in amplifying nucleic acids. This method utilizes a reaction volume heated with electrical energy, where the ratio of electrical energy used in the denaturation step is less than 20 Joules per milliliter of the reaction volume. Furthermore, he introduced a novel device that includes a reaction vessel and a heating component with heating elements that are conjugated to oligonucleotides, enhancing the efficiency of nucleic acid amplification.
Additionally, another significant patent by Buersgens involves the use of nanoparticles conjugated with oligonucleotides for the multiplication of nucleic acids. This method encompasses a multiplication step and a subsequent test step to determine the concentration of the reaction products. The potential heat transfer capabilities of nanoparticles upon excitation add a unique dimension to the amplification process, making it a noteworthy advancement in the field.
Career Highlights
Buersgens has played an influential role in companies such as GNA Biosolutions GmbH and HP Health Solutions Germany GmbH, where his expertise in molecular biology and innovative technologies has been greatly valued. His work has not only laid the groundwork for pioneering innovations but has also set a precedent for future research in nucleic acid amplification.
Collaborations
Throughout his career, Buersgens has collaborated with notable individuals in the field, such as Joachim Stehr and Lars Ullerich. These collaborative efforts have fostered an environment of innovation and have contributed to the development of advanced methodologies that address real-world challenges in molecular diagnostics.
Conclusion
Federico Buersgens stands as a prominent figure in the realm of molecular biology, with his innovative contributions paving the way for enhanced techniques in nucleic acid amplification. His patents showcase a deep understanding of the intricacies involved in PCR and highlight the importance of inventive approaches in advancing scientific research and technology. As the field evolves, Buersgens's work will undoubtedly continue to influence future advancements in this crucial area of study.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile